Eton Pharmaceuticals, Inc.ETONNASDAQ

Revenue (LTM)

$80M

+104.9% YoY

Net Income (LTM)

$-5M

-20.4% YoY

Free Cash Flow

$10M

Revenue CAGR (5Y)

+359.6%

Marginsdeclining

FCF$0.0B

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	22	21↓2.7%	32↑48.9%	39↑23.3%	80↑104.9%
Gross Profit	19	14↓25.5%	21↑47.1%	23↑11.2%	43↑82.6%
Operating Income	-1	-8↓452.5%	-1↑85.6%	-3↓117.9%	-1↑67.5%
Net Income	-2	-9↓361.4%	-1↑89.6%	-4↓308.4%	-5↓20.4%
EBITDA	-1	-6↓527.9%	-0↑95.5%	-1↓398.6%	-1↑41.8%
EPS Diluted	-0.08	-0.36↓363.9%	-0.04↑89.9%	-0.15↓311.0%	-0.17↓13.3%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	14	16↑13.2%	21↑31.2%	15↓30.2%	26↑73.7%
Total Current Assets	24	20↓15.3%	27↑34.2%	41↑52.8%	61↑47.7%
Total Assets	27	25↓8.9%	32↑26.8%	76↑139.8%	92↑21.0%
Total Current Liabilities	5	6↑41.8%	16↑151.4%	20↑22.8%	38↑93.0%
Total Liabilities	10	12↑21.5%	16↑36.1%	52↑217.9%	66↑27.6%
Total Equity	18	13↓25.8%	15↑18.3%	24↑57.8%	26↑7.1%
Total Debt	7	7↓2.6%	5↓17.2%	30↑453.8%	9↓69.1%
Net Debt	-8	-10↓26.8%	-16↓63.4%	15↑193.7%	-17↓211.4%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-5	5↑202.1%	7↑41.4%	1↓85.8%	11↑986.1%
Capital Expenditure	-3	-3↑14.5%	-1↑72.2%	-0↑96.6%	-0↓1180.8%
Free Cash Flow	-8	2↑125.5%	6↑197.1%	1↓84.4%	10↑980.7%
Stock-Based Comp	3	4↑24.8%	3↓25.6%	3↑0.9%	6↑74.2%
Net Change in Cash	-7	2↑127.6%	5↑167.7%	-6↓226.9%	11↑270.6%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance